Dublin, Ireland, 25 August 2020 – Orphan Drug Consulting is delighted to welcome Mike Gannon to its growing international consulting team.
Mike specializes in helping organizations grow and develop internationally as well as advising on optimum structures for finance, tax, treasury and business administration and support functions. Providing this expert advice to Orphan Drug Consulting clients addresses this growing and strategic part of our consulting business.
Mike has over 25 years of financial leadership within the pharmaceutical services and wider healthcare and technology sectors. Most recently, he has held roles as Chief Financial Officer in both the healthcare and construction industries, and prior to these spent 10 years with UDG Healthcare plc where, as a member of the senior leadership team, Mike played a key role in developing and implementing its international growth strategy and also had responsibility for putting in place appropriate business structures to support this expansion.
Mike trained at Coopers & Lybrand (now PricewaterhouseCoopers) where he qualified as a Chartered Accountant (FCA) and holds a Bachelor of Commerce degree from the National University of Ireland in Galway. Mike also has a Diploma in Professional Accounting (DPA) from University College Dublin and has completed the Stanford Executive Program in Stanford Graduate School of Business.
Evelyn Kelly, Managing Director of Orphan Drug Consulting commented on Mike’s appointment: “I am delighted to welcome Mike and his experience to the team at Orphan Drug Consulting. Effective financial planning and entity establishment is key to our clients as they expand markets for their innovative products. Mike’s significant experience in this growing strategic area of our business helps us continue to address our clients needs. Coupled to his executive leadership background Mike makes a great addition to our growing team and, most importantly, to our clients. I look forward to working closely with him in the future.”
Mike adds: “I am delighted to join Orphan Drug Consulting at this exciting time. I have seen the company growing its expert consultants and expanding its services to best match the needs of its clients. I look forward to working with all the team and providing strategic advice to our clients to ensure they optimise their structures supporting patient access to their important products”.
About Orphan Drug Consulting Ltd
Orphan Drug Consulting coordinate product launch into US, EU, and other international markets, providing strategic support in the areas of supply chain, quality assurance, vendor management and entity management with its team of experienced industry professionals. From full-service solutions to solving specific immediate requirements, Orphan Drug Consulting is your partner of choice to manage market complexities ensuring your successful product launch to meet your patients’ needs.
Leave a reply